50 related articles for article (PubMed ID: 38719736)
1.
Med Decis Making; 2024 May; ():272989X241258539. PubMed ID: 38804642
[No Abstract] [Full Text] [Related]
2. Multidisciplinary meeting review in nonsmall cell lung cancer: a systematic review and meta-analysis.
Stirling RG; Harrison A; Huang J; Lee V; Taverner J; Barnes H
Eur Respir Rev; 2024 Apr; 33(172):. PubMed ID: 38719736
[TBL] [Abstract][Full Text] [Related]
3. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Ettinger DS; Wood DE; Aisner DL; Akerley W; Bauman JR; Bharat A; Bruno DS; Chang JY; Chirieac LR; D'Amico TA; DeCamp M; Dilling TJ; Dowell J; Gettinger S; Grotz TE; Gubens MA; Hegde A; Lackner RP; Lanuti M; Lin J; Loo BW; Lovly CM; Maldonado F; Massarelli E; Morgensztern D; Ng T; Otterson GA; Pacheco JM; Patel SP; Riely GJ; Riess J; Schild SE; Shapiro TA; Singh AP; Stevenson J; Tam A; Tanvetyanon T; Yanagawa J; Yang SC; Yau E; Gregory K; Hughes M
J Natl Compr Canc Netw; 2022 May; 20(5):497-530. PubMed ID: 35545176
[TBL] [Abstract][Full Text] [Related]
4. Quality and efficacy of Multidisciplinary Team (MDT) quality assessment tools and discussion checklists: a systematic review.
Brown GTF; Bekker HL; Young AL
BMC Cancer; 2022 Mar; 22(1):286. PubMed ID: 35300636
[TBL] [Abstract][Full Text] [Related]
5. Impacts of lung cancer multidisciplinary meeting presentation: Drivers and outcomes from a population registry retrospective cohort study.
Lin T; Pham J; Paul E; Conron M; Wright G; Ball D; Mitchell P; Atkin N; Brand M; Zalcberg J; Stirling RG
Lung Cancer; 2022 Jan; 163():69-76. PubMed ID: 34923204
[TBL] [Abstract][Full Text] [Related]
6. Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group.
Guirado M; Sanchez-Hernandez A; Pijuan L; Teixido C; Gómez-Caamaño A; Cilleruelo-Ramos Á
Clin Transl Oncol; 2022 Mar; 24(3):446-459. PubMed ID: 34665437
[TBL] [Abstract][Full Text] [Related]
7. Survival Impact of an Enhanced Multidisciplinary Thoracic Oncology Conference in a Regional Community Health Care System.
Ray MA; Faris NR; Fehnel C; Derrick A; Smeltzer MP; Meadows-Taylor MB; Ariganjoye F; Pacheco A; Optican R; Tonkin K; Wright J; Fox R; Callahan T; Robbins ET; Walsh W; Lammers P; Satpute S; Osarogiagbon RU
JTO Clin Res Rep; 2021 Aug; 2(8):100203. PubMed ID: 34590046
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer.
Shukla N; Hanna N
Lung Cancer (Auckl); 2021; 12():51-60. PubMed ID: 34234606
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary team discussion results in survival benefit for patients with stage III non-small-cell lung cancer.
Hung HY; Tseng YH; Chao HS; Chiu CH; Hsu WH; Hsu HS; Wu YC; Chou TY; Chen CK; Lan KL; Chen YW; Wu YH; Chen YM
PLoS One; 2020; 15(10):e0236503. PubMed ID: 33031375
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer recurrence and mortality outcomes over a 10-year period using a multidisciplinary team approach.
Nemesure B; Albano D; Bilfinger T
Cancer Epidemiol; 2020 Oct; 68():101804. PubMed ID: 32896806
[TBL] [Abstract][Full Text] [Related]
11. Variation Between Multidisciplinary Tumor Boards in Clinical Staging and Treatment Recommendations for Patients With Locally Advanced Non-small Cell Lung Cancer.
Hoeijmakers F; Heineman DJ; Daniels JM; Beck N; Tollenaar RAEM; Wouters MWJM; Marang-van de Mheen PJ; Schreurs WH;
Chest; 2020 Dec; 158(6):2675-2687. PubMed ID: 32738254
[TBL] [Abstract][Full Text] [Related]
12. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments.
McGuinness LA; Higgins JPT
Res Synth Methods; 2021 Jan; 12(1):55-61. PubMed ID: 32336025
[TBL] [Abstract][Full Text] [Related]
13. Patient and physician perceptions of lung cancer care in a multidisciplinary clinic model.
Linford G; Egan R; Coderre-Ball A; Dalgarno N; Stone CJL; Robinson A; Robinson D; Wakeham S; Digby GC
Curr Oncol; 2020 Feb; 27(1):e9-e19. PubMed ID: 32218663
[TBL] [Abstract][Full Text] [Related]
14. Correction to: "Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up".
Planchard D; Popat S; Kerr K; Novello S; Smit EF; Faivre-Finn C; Mok TS; Reck M; Van Schil PE; Hellmann MD; Peters S
Ann Oncol; 2019 May; 30(5):863-870. PubMed ID: 31987360
[No Abstract] [Full Text] [Related]
15. Interprofessional Lung Cancer Tumor Board: The Role of the Oncology Nurse Navigator in Improving Adherence to National Guidelines and Streamlining Patient Care.
Peckham J; Mott-Coles S
Clin J Oncol Nurs; 2018 Dec; 22(6):656-662. PubMed ID: 30452006
[TBL] [Abstract][Full Text] [Related]
16. Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort study.
Stone E; Rankin N; Kerr S; Fong K; Currow DC; Phillips J; Connon T; Zhang L; Shaw T
Lung Cancer; 2018 Oct; 124():199-204. PubMed ID: 30268461
[TBL] [Abstract][Full Text] [Related]
17. Making the Evidentiary Case for Universal Multidisciplinary Thoracic Oncologic Care.
Osarogiagbon RU
Clin Lung Cancer; 2018 Jul; 19(4):294-300. PubMed ID: 29934139
[TBL] [Abstract][Full Text] [Related]
18. Survival Outcomes Among Lung Cancer Patients Treated Using a Multidisciplinary Team Approach.
Bilfinger TV; Albano D; Perwaiz M; Keresztes R; Nemesure B
Clin Lung Cancer; 2018 Jul; 19(4):346-351. PubMed ID: 29506890
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
